, ginkgolic acid (17 : 1) (42% inhibition), and 18β-glycyrrhetinic acid (56% inhibition) each significantly inhibited hOAT1-mediated PAH uptake at 50-fold excess. Here, SLC22A6 is linked to pulmonary arterial hypertension.